Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635542 · ClinicalTrials.gov registry record · Phase 4
Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT02635542 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 100 participants.
The verdict
NCT02635542, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The investigators will conduct a prospective, randomized trial to assess the impact of neuromuscular blockade on early (\<72 hours post-ICU admission) postoperative respiratory complications in cardiac surgical patients. The study will compare continual neuromuscular blockade with cisatracurium to a single dose of succinylcholine during general anesthesia for cardiac surgery.
Interventions
- DRUG Cisatracurium
- DRUG Succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-09-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02635542
The ClinicalTrials.gov registry entry for NCT02635542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cisatracurium is the first listed.
NCT02635542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02635542 about?
NCT02635542 is a clinical study titled "Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery". The investigators will conduct a prospective, randomized trial to assess the impact of neuromuscular blockade on early (\<72 hours post-ICU admission) postoperative respiratory complications in cardiac surgical patients. The study will compare continual neuromuscular blockade with cisatracurium to a...
What is the current status of trial NCT02635542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2016-03. Estimated completion is 2017-09-15.
What interventions are being tested in trial NCT02635542?
The interventions under investigation include: Cisatracurium (DRUG), Succinylcholine (DRUG).
Who is sponsoring clinical trial NCT02635542?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.